Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 20, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Paul Fisher, MD, and Gerald Grant, MD, FACS, on how their team at the center is bolstering the use of multidisciplinary care and harnessing advances in science to improve the care of children with neurologic disease.
An overview of the NeurologyLive tweet chat, cohosted by the Dravet Syndrome Foundation, Lennox-Gastaut Syndrome Foundation, and the Tuberous Sclerosis Alliance, and honoring National Epilepsy Awareness Month, featuring highlighted contributions from the medical community.
In this episode, the panel of Fred Lublin, MD; Patricia K. Coyle, MD; Scott Newsome, DO, MSCS, FAAN; and Mark Freedman, MD, outline the importance of the use of MRI in the diagnosis of multiple sclerosis.
The vice president of Clinical Research at Eisai provides updates on the MOMENTUM trials which will examine lorcaserin as a potential treatment for patients with Dravet syndrome.
The professor from the Universite de Sherbrooke discusses how brain energy rescue is emerging as a promising strategy to early combat neurodegenerative disorders before significant impairment occurs, and other factors that increase cognitive decline in patients with MCI.